COMMUNIQUÉS West-GlobeNewswire
-
Clearmind Medicine Announces Publication of Six Innovative Patents in Hong Kong for Next-Generation Psychedelic-Based Combination Therapies
17/03/2026 -
Moleculin to Present at 38th Annual ROTH Conference
17/03/2026 -
Acumen Pharmaceuticals Presents Studies on Enhanced Brain Delivery™, Biomarker Research, and Novel Antibodies at Advances in Alzheimer's Treatment at International Conference on Alzheimer’s and Parkinson’s Diseases 2026
17/03/2026 -
Science 37 Launches Dedicated Pediatrics Department to Expand Access to Specialized Clinical Research for Children and Families
17/03/2026 -
Abeona Therapeutics® Reports Full Year 2025 Financial Results and Corporate Updates
17/03/2026 -
Former Peloton and Equinox Design Leader Cecilia Farooqi Joins Noom as Head of Product Design
17/03/2026 -
Liminatus Pharma Announces Planned Phase 1 Clinical Trial of IBA101, a Next-Generation CD47 Blocking Antibody
17/03/2026 -
Elicio Therapeutics Reports Inducement Grants
17/03/2026 -
Galectin Therapeutics Strengthens Board of Directors with Appointment of Henry Brem, M.D.
17/03/2026 -
Humacyte Submits Marketing Authorization Application for Symvess® in Israel for Vascular Trauma Repair
17/03/2026 -
CoRegen, Inc. Publishes Promising New Data Highlighting SRC-3 Engineered Regulatory T Cells as New Immunotherapy Platform
17/03/2026 -
HNL Lab Medicine Expands Access to Diagnostic Testing with New Wilkes-Barre Patient Service Center
17/03/2026 -
Center for Radiology Education Launches Nationwide Initiative to Provide Medical Imaging Scholarships at John Patrick University
17/03/2026 -
Anavex Life Sciences Presents Significant Treatment Effects of Blarcamesine in New Advanced Alpha-Synuclein Model of Parkinson’s Disease at AD/PD 2026 Conference
17/03/2026 -
Candel Therapeutics Reports Extended Survival Tail Observed in Trial of Aglatimagene Besadenovec (CAN-2409) in Advanced Non-Small Cell Lung Cancer Patients with Inadequate Response to Immune Checkpoint Inhibitors
17/03/2026 -
Bionano Announces Two-Fold Increase in OGM Studies Presented at the 2026 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting
17/03/2026 -
Cognition Therapeutics Presents Evidence of Zervimesine’s Impact on Neuropsychiatric Symptoms of Dementia with Lewy Bodies at AD/PD 2026
17/03/2026 -
PatchMD Named the World’s #1 Vitamin Patch Brand in 2026 — And It’s Not Even Close
17/03/2026 -
Neuronetics Appoints Dan Reuvers as President and Chief Executive Officer
17/03/2026
Pages